Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
31
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| JAIN ABHINAV | Director | 3 | $0 | $0 | 2026-08-15 |
| Beeson Jonn R. | Director | 7 | $0 | $0 | 2026-08-15 |
| Schallenberger Mark A. | Chief Operations Officer | 13 | $0 | $0 | 2026-08-15 |
| Neils Scott C | Interim Chief Financial Office | 21 | $0 | $8.3K | 2026-08-15 |
| Browne Sean E | President and Chief Executive | 21 | $0 | $86.1K | 2026-08-15 |
| Vizirgianakis Stavros G. | Director | 11 | $1.09M | $0 | 2026-08-15 |
| Lipschultz Tyler | Director | 3 | $0 | $0 | 2026-08-15 |
| BAKEWELL JOHN K | Director | 12 | $0 | $0 | 2026-08-15 |
| Orbimed ROF II LLC | Director, 10% Owner | 14 | $0 | $30.71M | 2025-04-10 |
| Brandt Kevin D | VP & Chief Commercial Officer | 19 | $50.0K | $11.2K | 2024-08-15 |
| McNamara Robert | Director | 8 | $0 | $0 | 2024-08-15 |
| MITCHELL-KELLER LORI D | Director | 4 | $0 | $0 | 2024-08-15 |
| Eggenberg Michael | Director, 10% Owner | 32 | $6.81M | $0 | 2022-08-15 |
| Rizzo Matthew | Director, 10% Owner | 32 | $6.81M | $0 | 2022-08-15 |
| Peters Jeffrey J | Director | 5 | $0 | $0 | 2022-08-15 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 24 | $6.81M | $0 | 2022-08-15 |
| JENSEN GREG | Vice President, Finance & CFO | 6 | $0 | $0 | 2021-08-15 |
| Berlin Ronald G. | VP & Chief Operations Officer | 1 | $0 | $0 | 2019-01-15 |
| Mainelli Michael | Interim CEO | 2 | $0 | $0 | 2018-10-15 |
| Lenzen Kathie J. | Chief Financial Officer | 1 | $0 | $0 | 2018-09-15 |
| O'Connell Carl | President | 2 | $0 | $0 | 2018-08-15 |
| TIMKO ERIC BERNARD | Director | 2 | $0 | $0 | 2017-07-25 |
| Mazzocchi Rudy A | Director | 2 | $0 | $0 | 2017-07-25 |
| DEEDRICK JOHN ARTHUR | Director | 4 | $0 | $0 | 2017-07-25 |
| LOPACH MICHAEL A | Director | 4 | $0 | $0 | 2017-07-25 |
| Swanson Kent L | Director | 16 | $24.3K | $0 | 2017-07-25 |
| BUCKMAN PAUL | Director | 2 | $0 | $0 | 2017-07-25 |
| Goldberger Daniel S | Chief Executive Officer | 5 | $20.1K | $0 | 2016-11-17 |
| Kirschman David Louis | EVP & Chief Scientific Officer | 5 | $11.8K | $0 | 2016-07-02 |
| WICKWIRE JON M. | Other | 2 | $0 | $0 | 2016-07-01 |
| Goodman David | Other | 2 | $0 | $0 | 2016-07-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Browne Sean E | President and CEO | F Tax w/h | 2026-08-15 | 2026-08-18 | 10,605 | $0.31 | $3.3K | 3,114,669 | SEC↗ |
| Browne Sean E | President and CEO | A Award | 2026-08-15 | 2026-08-18 | 550,000 | — | $0 | 3,125,274 | SEC↗ |
| Neils Scott C | CFO and Assistant Secretary | A Award | 2026-08-15 | 2026-08-18 | 400,000 | — | $0 | 1,243,381 | SEC↗ |
| Neils Scott C | CFO and Assistant Secretary | F Tax w/h | 2026-08-15 | 2026-08-18 | 28,155 | $0.31 | $8.7K | 1,215,226 | SEC↗ |
| Schallenberger Mark A. | Chief Operating Officer | F Tax w/h | 2026-08-15 | 2026-08-18 | 7,070 | $0.31 | $2.2K | 1,106,087 | SEC↗ |
| Schallenberger Mark A. | Chief Operating Officer | A Award | 2026-08-15 | 2026-08-18 | 450,000 | — | $0 | 1,113,157 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award | 2026-08-15 | 2026-08-18 | 323,275 | — | $0 | 7,838,845 | SEC↗ |
| JAIN ABHINAV | Director | A Award | 2026-08-15 | 2026-08-18 | 215,517 | — | $0 | 373,745 | SEC↗ |
| Beeson Jonn R. | Director | A Award | 2026-08-15 | 2026-08-18 | 215,517 | — | $0 | 733,136 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2026-08-15 | 2026-08-18 | 215,517 | — | $0 | 1,129,633 | SEC↗ |
| Lipschultz Tyler | Director | A Award | 2026-08-15 | 2026-08-18 | 215,517 | — | $0 | 373,745 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award | 2026-08-15 | 2026-08-18 | 323,275 | — | $0 | 7,838,845 | SEC↗ |
| Schallenberger Mark A. | Chief Operating Officer | F Tax w/h | 2026-08-15 | 2026-08-18 | 7,070 | $0.31 | $2.2K | 1,106,087 | SEC↗ |
| Schallenberger Mark A. | Chief Operating Officer | A Award | 2026-08-15 | 2026-08-18 | 450,000 | — | $0 | 1,113,157 | SEC↗ |
| Neils Scott C | CFO and Assistant Secretary | F Tax w/h | 2026-08-15 | 2026-08-18 | 28,155 | $0.31 | $8.7K | 1,215,226 | SEC↗ |
| Neils Scott C | CFO and Assistant Secretary | A Award | 2026-08-15 | 2026-08-18 | 400,000 | — | $0 | 1,243,381 | SEC↗ |
| Lipschultz Tyler | Director | A Award | 2026-08-15 | 2026-08-18 | 215,517 | — | $0 | 373,745 | SEC↗ |
| JAIN ABHINAV | Director | A Award | 2026-08-15 | 2026-08-18 | 215,517 | — | $0 | 373,745 | SEC↗ |
| Browne Sean E | President and CEO, Director | F Tax w/h | 2026-08-15 | 2026-08-18 | 10,605 | $0.31 | $3.3K | 3,114,669 | SEC↗ |
| Browne Sean E | President and CEO, Director | A Award | 2026-08-15 | 2026-08-18 | 550,000 | — | $0 | 3,125,274 | SEC↗ |
| Beeson Jonn R. | Director | A Award | 2026-08-15 | 2026-08-18 | 215,517 | — | $0 | 733,136 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2026-08-15 | 2026-08-18 | 215,517 | — | $0 | 1,129,633 | SEC↗ |
| Schallenberger Mark A. | Chief Operating Officer | F Tax w/h | 2026-02-15 | 2026-02-18 | 7,709 | $0.58 | $4.5K | 663,157 | SEC↗ |
| Neils Scott C | CFO and Assistant Secretary | F Tax w/h | 2026-01-15 | 2026-01-16 | 8,084 | $0.65 | $5.3K | 843,381 | SEC↗ |
| Neils Scott C | CFO and Assistant Secretary | A Award deriv | 2025-11-15 | 2025-11-18 | 526,582 | — | $0 | 526,582 | SEC↗ |
| Schallenberger Mark A. | Chief Operating Officer | A Award deriv | 2025-11-15 | 2025-11-18 | 584,506 | — | $0 | 584,506 | SEC↗ |
| Browne Sean E | President and CEO | A Award deriv | 2025-11-15 | 2025-11-18 | 789,874 | — | $0 | 789,874 | SEC↗ |
| Neils Scott C | CFO and Assistant Secretary | A Award | 2025-11-15 | 2025-11-18 | 263,291 | — | $0 | 851,465 | SEC↗ |
| Schallenberger Mark A. | Chief Operating Officer | A Award | 2025-11-15 | 2025-11-18 | 292,253 | — | $0 | 670,866 | SEC↗ |
| Browne Sean E | President and CEO | A Award | 2025-11-15 | 2025-11-18 | 394,937 | — | $0 | 2,575,274 | SEC↗ |
| Lipschultz Tyler | Director | A Award | 2025-11-15 | 2025-11-18 | 158,228 | — | $0 | 158,228 | SEC↗ |
| JAIN ABHINAV | Director | A Award | 2025-11-15 | 2025-11-18 | 158,228 | — | $0 | 158,228 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2025-11-15 | 2025-11-18 | 158,228 | — | $0 | 158,228 | SEC↗ |
| Beeson Jonn R. | Director | A Award | 2025-11-15 | 2025-11-18 | 158,228 | — | $0 | 517,619 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award | 2025-11-15 | 2025-11-18 | 553,797 | — | $0 | 7,515,570 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2025-11-15 | 2025-11-18 | 158,228 | — | $0 | 914,116 | SEC↗ |
| Neils Scott C | CFO | F Tax w/h | 2025-08-15 | 2025-08-19 | 34,131 | $0.63 | $21.5K | 588,174 | SEC↗ |
| Browne Sean E | President and CEO | F Tax w/h | 2025-08-15 | 2025-08-19 | 10,605 | $0.63 | $6.7K | 2,180,337 | SEC↗ |
| Orbimed ROF II LLC | 10% Owner | S Sale | 2025-04-10 | 2025-04-14 | 56,004,974 | $0.42 | $23.52M | 0 | SEC↗ |
| Orbimed ROF II LLC | 10% Owner | S Sale | 2025-04-10 | 2025-04-14 | 17,109,618 | $0.42 | $7.19M | 0 | SEC↗ |
| Neils Scott C | Chief Financial Officer | F Tax w/h | 2025-01-15 | 2025-01-17 | 7,986 | $0.53 | $4.2K | 622,305 | SEC↗ |
| Browne Sean E | President and CEO | F Tax w/h | 2024-10-15 | 2024-10-16 | 105,442 | $0.59 | $62.2K | 2,190,942 | SEC↗ |
| Browne Sean E | President and CEO | F Tax w/h | 2024-08-15 | 2024-08-19 | 10,606 | $0.60 | $6.4K | 2,296,384 | SEC↗ |
| Neils Scott C | Chief Financial Officer | F Tax w/h | 2024-08-15 | 2024-08-19 | 34,132 | $0.60 | $20.5K | 630,291 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | F Tax w/h | 2024-08-15 | 2024-08-19 | 56,333 | $0.60 | $33.8K | 943,736 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2024-08-15 | 2024-08-19 | 162,162 | — | $0 | 755,888 | SEC↗ |
| Beeson Jonn R. | Director | A Award | 2024-08-15 | 2024-08-19 | 162,162 | — | $0 | 359,391 | SEC↗ |
| McNamara Robert | Director | A Award | 2024-08-15 | 2024-08-19 | 162,162 | — | $0 | 754,151 | SEC↗ |
| MITCHELL-KELLER LORI D | Director | A Award | 2024-08-15 | 2024-08-19 | 162,162 | — | $0 | 353,124 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award | 2024-08-15 | 2024-08-19 | 243,243 | — | $0 | 6,456,368 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award | 2024-08-15 | 2024-08-19 | 505,405 | — | $0 | 6,961,773 | SEC↗ |
| Schallenberger Mark A. | Chief Operations Officer | A Award | 2024-04-03 | 2025-01-17 | 173,469 | — | $0 | 378,613 | SEC↗ |
| Neils Scott C | Chief Financial Officer | A Award | 2024-04-03 | 2024-04-05 | 177,551 | — | $0 | 664,423 | SEC↗ |
| Schallenberger Mark A. | Chief Operations Officer | A Award | 2024-04-03 | 2024-04-05 | 177,551 | — | $0 | 382,695 | SEC↗ |
| Browne Sean E | President and CEO | A Award | 2024-04-03 | 2024-04-05 | 731,632 | — | $0 | 2,306,990 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award | 2024-04-03 | 2024-04-05 | 184,209 | — | $0 | 1,000,069 | SEC↗ |
| Neils Scott C | Chief Financial Officer | F Tax w/h | 2024-01-16 | 2024-01-18 | 7,986 | $1.09 | $8.7K | 486,872 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | P Buy | 2023-11-17 | 2023-11-17 | 41,670 | $1.20 | $50.0K | 815,860 | SEC↗ |
| Browne Sean E | President and CEO | F Tax w/h | 2023-10-15 | 2024-02-16 | 105,442 | $1.08 | $113.9K | 1,575,358 | SEC↗ |
| Browne Sean E | President and CEO | F Tax w/h | 2023-10-15 | 2023-10-17 | 111,721 | $1.08 | $120.7K | 1,569,079 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award deriv | 2023-08-15 | 2023-08-17 | 28,230 | — | $0 | 28,230 | SEC↗ |
| Beeson Jonn R. | Director | A Award deriv | 2023-08-15 | 2023-08-17 | 28,230 | — | $0 | 28,230 | SEC↗ |
| McNamara Robert | Director | A Award deriv | 2023-08-15 | 2023-08-17 | 28,230 | — | $0 | 28,230 | SEC↗ |
| MITCHELL-KELLER LORI D | Director | A Award deriv | 2023-08-15 | 2023-08-17 | 28,230 | — | $0 | 28,230 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award deriv | 2023-08-15 | 2023-08-17 | 42,345 | — | $0 | 42,345 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award deriv | 2023-08-15 | 2023-08-17 | 140,583 | — | $0 | 140,583 | SEC↗ |
| Browne Sean E | President and CEO | A Award deriv | 2023-08-15 | 2023-08-17 | 203,252 | — | $0 | 203,252 | SEC↗ |
| Neils Scott C | Chief Financial Officer | A Award deriv | 2023-08-15 | 2023-08-17 | 135,501 | — | $0 | 135,501 | SEC↗ |
| Schallenberger Mark A. | Chief Operations Officer | A Award deriv | 2023-08-15 | 2023-08-17 | 135,501 | — | $0 | 135,501 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2023-08-15 | 2023-08-17 | 145,180 | — | $0 | 593,726 | SEC↗ |
| Beeson Jonn R. | Director | A Award | 2023-08-15 | 2023-08-17 | 145,180 | — | $0 | 197,229 | SEC↗ |
| McNamara Robert | Director | A Award | 2023-08-15 | 2023-08-17 | 145,180 | — | $0 | 591,989 | SEC↗ |
| MITCHELL-KELLER LORI D | Director | A Award | 2023-08-15 | 2023-08-17 | 145,180 | — | $0 | 190,962 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award | 2023-08-15 | 2023-08-17 | 217,770 | — | $0 | 6,213,125 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | F Tax w/h | 2023-08-15 | 2023-08-17 | 49,880 | $1.18 | $58.9K | 774,190 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award | 2023-08-15 | 2023-08-17 | 120,499 | — | $0 | 824,070 | SEC↗ |
| Browne Sean E | President and CEO | A Award | 2023-08-15 | 2023-08-17 | 174,216 | — | $0 | 1,680,800 | SEC↗ |
| Neils Scott C | Chief Financial Officer | F Tax w/h | 2023-08-15 | 2023-08-17 | 25,246 | $1.18 | $29.8K | 494,858 | SEC↗ |
| Neils Scott C | Chief Financial Officer | A Award | 2023-08-15 | 2023-08-17 | 116,144 | — | $0 | 520,104 | SEC↗ |
| Schallenberger Mark A. | Chief Operations Officer | A Award | 2023-08-15 | 2023-08-17 | 116,144 | — | $0 | 205,144 | SEC↗ |
| MITCHELL-KELLER LORI D | Director | A Award | 2023-06-15 | 2023-06-15 | 45,782 | — | $0 | 45,782 | SEC↗ |
| Beeson Jonn R. | Director | A Award | 2023-05-15 | 2023-05-16 | 52,049 | — | $0 | 52,049 | SEC↗ |
| Schallenberger Mark A. | Chief Operations Officer | A Award deriv | 2023-02-15 | 2023-02-17 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Schallenberger Mark A. | Chief Operations Officer | A Award | 2023-02-15 | 2023-02-17 | 89,000 | — | $0 | 89,000 | SEC↗ |
| Neils Scott C | Chief Financial Officer | S Sale | 2023-01-18 | 2023-01-19 | 8,673 | $0.61 | $5.3K | 403,960 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award | 2022-11-15 | 2022-11-17 | 144,639 | — | $0 | 5,995,355 | SEC↗ |
| Browne Sean E | President and CEO | S Sale | 2022-10-19 | 2022-10-20 | 51,100 | $0.62 | $31.7K | 1,506,584 | SEC↗ |
| Browne Sean E | President and CEO | S Sale | 2022-10-18 | 2022-10-20 | 80,000 | $0.68 | $54.4K | 1,557,684 | SEC↗ |
| Vizirgianakis Stavros G. | Director | P Buy deriv | 2022-10-07 | 2022-10-11 | 566,214 | — | $0 | 566,214 | SEC↗ |
| Vizirgianakis Stavros G. | Director | P Buy | 2022-10-07 | 2022-10-11 | 2,264,861 | $0.48 | $1.09M | 5,850,716 | SEC↗ |
| Vizirgianakis Stavros G. | Director | A Award | 2022-08-25 | 2022-08-26 | 70,776 | — | $0 | 3,585,855 | SEC↗ |
| Neils Scott C | Chief Financial Officer | S Sale | 2022-08-17 | 2022-08-17 | 1,270 | $0.48 | $610 | 412,633 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | S Sale | 2022-08-17 | 2022-08-17 | 4,300 | $0.48 | $2.1K | 703,571 | SEC↗ |
| Neils Scott C | Chief Financial Officer | S Sale | 2022-08-16 | 2022-08-17 | 5,100 | $0.48 | $2.4K | 413,903 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | S Sale | 2022-08-16 | 2022-08-17 | 18,700 | $0.49 | $9.2K | 707,871 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award | 2022-08-15 | 2022-08-17 | 215,415 | — | $0 | 215,415 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award | 2022-08-15 | 2022-08-17 | 215,415 | — | $0 | 215,415 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | J Other | 2022-08-15 | 2022-08-17 | 215,415 | — | $0 | 215,415 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | J Other | 2022-08-15 | 2022-08-17 | 215,415 | — | $0 | 215,415 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2022-08-15 | 2022-08-17 | 215,415 | — | $0 | 448,546 | SEC↗ |
| McNamara Robert | Director | A Award | 2022-08-15 | 2022-08-17 | 215,415 | — | $0 | 446,809 | SEC↗ |
| Peters Jeffrey J | Director | A Award | 2022-08-15 | 2022-08-17 | 215,415 | — | $0 | 448,546 | SEC↗ |
| Neils Scott C | Chief Financial Officer | A Award | 2022-08-15 | 2022-08-17 | 251,895 | — | $0 | 419,003 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award | 2022-08-15 | 2022-08-17 | 410,079 | — | $0 | 726,571 | SEC↗ |
| Neils Scott C | Interim Chief Financial Offi | A Award deriv | 2022-01-15 | 2022-01-18 | 109,164 | — | $0 | 109,164 | SEC↗ |
| Neils Scott C | Interim Chief Financial Offi | A Award | 2022-01-15 | 2022-01-18 | 88,983 | — | $0 | 167,108 | SEC↗ |
| Browne Sean E | President and CEO | F Tax w/h | 2021-10-15 | 2021-10-18 | 160,219 | $1.11 | $177.8K | 1,637,684 | SEC↗ |
| JENSEN GREG | Vice President, Finance & CF | A Award deriv | 2021-08-15 | 2021-08-17 | 192,308 | — | $0 | 192,308 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award deriv | 2021-08-15 | 2021-08-17 | 199,519 | — | $0 | 199,519 | SEC↗ |
| JENSEN GREG | Vice President, Finance & CF | A Award | 2021-08-15 | 2021-08-17 | 156,250 | — | $0 | 285,331 | SEC↗ |
| Rizzo Matthew | Director | A Award | 2021-08-15 | 2021-08-17 | 85,337 | — | $0 | 120,549 | SEC↗ |
| Eggenberg Michael | Director | A Award | 2021-08-15 | 2021-08-17 | 85,337 | — | $0 | 120,549 | SEC↗ |
| McNamara Robert | Director | A Award | 2021-08-15 | 2021-08-17 | 85,337 | — | $0 | 231,394 | SEC↗ |
| Peters Jeffrey J | Director | A Award | 2021-08-15 | 2021-08-17 | 85,337 | — | $0 | 233,131 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2021-08-15 | 2021-08-17 | 85,337 | — | $0 | 233,131 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | F Tax w/h | 2021-08-15 | 2021-08-17 | 7,169 | $1.20 | $8.6K | 316,492 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award | 2021-08-15 | 2021-08-17 | 162,109 | — | $0 | 323,661 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | J Other | 2021-08-15 | 2021-08-17 | 85,337 | — | $0 | 120,549 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | J Other | 2021-08-15 | 2021-08-17 | 85,337 | — | $0 | 120,549 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | F Tax w/h | 2021-07-09 | 2021-07-13 | 8,800 | $1.74 | $15.3K | 161,552 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 765,992 | — | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 434,008 | — | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 765,992 | — | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 434,008 | — | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 868,016 | — | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 1,531,984 | — | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 765,992 | — | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 434,008 | — | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 765,992 | — | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 434,008 | — | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 1,531,984 | — | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 868,016 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 765,992 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 868,016 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 1,531,984 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 434,008 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 765,992 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise deriv | 2020-11-17 | 2020-11-19 | 434,008 | — | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 1,531,984 | $0.01 | $15.3K | 55,766,352 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 434,008 | $0.01 | $4.3K | 16,168,704 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 434,008 | $0.01 | $4.3K | 15,734,696 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 868,016 | $0.01 | $8.7K | 17,036,720 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 765,992 | $0.01 | $7.7K | 54,234,368 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 765,992 | $0.01 | $7.7K | 53,468,376 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 434,008 | $0.01 | $4.3K | 15,734,696 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 765,992 | $0.01 | $7.7K | 53,468,376 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 765,992 | $0.01 | $7.7K | 54,234,368 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 1,531,984 | $0.01 | $15.3K | 55,766,352 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 434,008 | $0.01 | $4.3K | 16,168,704 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 868,016 | $0.01 | $8.7K | 17,036,720 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 1,531,984 | $0.01 | $15.3K | 55,766,352 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 434,008 | $0.01 | $4.3K | 16,168,704 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 434,008 | $0.01 | $4.3K | 15,734,696 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 868,016 | $0.01 | $8.7K | 17,036,720 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 765,992 | $0.01 | $7.7K | 54,234,368 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | X Exercise | 2020-11-17 | 2020-11-19 | 765,992 | $0.01 | $7.7K | 53,468,376 | SEC↗ |
| Browne Sean E | President and Chief Executiv | A Award deriv | 2020-11-15 | 2020-11-16 | 1,468,859 | — | $0 | 1,468,859 | SEC↗ |
| Browne Sean E | President and Chief Executiv | A Award | 2020-11-15 | 2020-11-16 | 1,468,859 | — | $0 | 1,797,903 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | A Award | 2020-10-01 | 2020-10-05 | 11,969,619 | $1.07 | $12.81M | 15,300,688 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | A Award | 2020-10-01 | 2020-10-05 | 46,784,775 | $1.07 | $50.06M | 52,702,384 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award | 2020-10-01 | 2020-10-05 | 46,784,775 | $1.07 | $50.06M | 52,702,384 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award | 2020-10-01 | 2020-10-05 | 11,969,619 | $1.07 | $12.81M | 15,300,688 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award | 2020-10-01 | 2020-10-05 | 11,969,619 | $1.07 | $12.81M | 15,300,688 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award | 2020-10-01 | 2020-10-05 | 46,784,775 | $1.07 | $50.06M | 52,702,384 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award deriv | 2020-08-15 | 2020-08-18 | 119,942 | — | $0 | 119,942 | SEC↗ |
| JENSEN GREG | VP, Finance and CFO | A Award deriv | 2020-08-15 | 2020-08-18 | 119,942 | — | $0 | 119,942 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award | 2020-08-15 | 2020-08-18 | 95,183 | — | $0 | 170,352 | SEC↗ |
| JENSEN GREG | VP, Finance and CFO | A Award | 2020-08-15 | 2020-08-18 | 95,183 | — | $0 | 129,081 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award deriv | 2020-05-06 | 2020-05-20 | 868,016 | — | $0 | 868,016 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award deriv | 2020-05-06 | 2020-05-20 | 1,531,984 | — | $0 | 1,531,984 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award deriv | 2020-05-06 | 2020-05-20 | 868,016 | — | $0 | 868,016 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award deriv | 2020-05-06 | 2020-05-20 | 1,531,984 | — | $0 | 1,531,984 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | A Award deriv | 2020-05-06 | 2020-05-20 | 868,016 | — | $0 | 868,016 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | A Award deriv | 2020-05-06 | 2020-05-20 | 1,531,984 | — | $0 | 1,531,984 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2020-02-05 | 2020-02-07 | 116,197 | — | $0 | 147,794 | SEC↗ |
| McNamara Robert | Director | A Award | 2020-02-05 | 2020-02-07 | 116,197 | — | $0 | 146,057 | SEC↗ |
| Peters Jeffrey J | Director | A Award | 2020-02-05 | 2020-02-07 | 116,197 | — | $0 | 147,794 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award | 2020-02-05 | 2020-02-07 | 70,423 | — | $0 | 91,256 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award | 2020-02-05 | 2020-02-07 | 70,423 | — | $0 | 91,256 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | J Other | 2020-02-05 | 2020-02-07 | 70,423 | — | $0 | 91,256 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | J Other | 2020-02-05 | 2020-02-07 | 70,423 | — | $0 | 91,256 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award | 2019-10-30 | 2019-10-31 | 20,833 | — | $0 | 20,833 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | J Other | 2019-10-30 | 2019-10-31 | 20,833 | — | $0 | 20,833 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | J Other | 2019-10-30 | 2019-10-31 | 20,833 | — | $0 | 20,833 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award | 2019-10-30 | 2019-10-31 | 20,833 | — | $0 | 20,833 | SEC↗ |
| Browne Sean E | President and CEO | A Award deriv | 2019-10-15 | 2019-10-15 | 329,044 | — | $0 | 329,044 | SEC↗ |
| Browne Sean E | President and CEO | A Award | 2019-10-15 | 2019-10-15 | 329,044 | — | $0 | 329,044 | SEC↗ |
| Peters Jeffrey J | Director | A Award | 2019-09-24 | 2019-09-25 | 5,555 | — | $0 | 31,597 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2019-09-24 | 2019-09-25 | 5,555 | — | $0 | 31,597 | SEC↗ |
| McNamara Robert | Director | A Award | 2019-09-24 | 2019-09-25 | 9,027 | — | $0 | 29,860 | SEC↗ |
| JENSEN GREG | VP, Finance & CFO | A Award deriv | 2019-08-15 | 2019-08-16 | 39,063 | — | $0 | 39,063 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award deriv | 2019-08-15 | 2019-08-16 | 40,527 | — | $0 | 40,527 | SEC↗ |
| JENSEN GREG | VP, Finance & CFO | A Award | 2019-08-15 | 2019-08-16 | 33,898 | — | $0 | 33,898 | SEC↗ |
| Brandt Kevin D | Chief Commercial Officer | A Award | 2019-08-15 | 2019-08-16 | 35,169 | — | $0 | 75,169 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | A Award deriv | 2019-04-01 | 2019-04-03 | 434,008 | — | $0 | 434,008 | SEC↗ |
| Orbimed ROF II LLC | Director, 10% Owner | A Award deriv | 2019-04-01 | 2019-04-03 | 765,992 | — | $0 | 765,992 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award deriv | 2019-04-01 | 2019-04-03 | 434,008 | — | $0 | 434,008 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award deriv | 2019-04-01 | 2019-04-03 | 765,992 | — | $0 | 765,992 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award deriv | 2019-04-01 | 2019-04-03 | 434,008 | — | $0 | 434,008 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award deriv | 2019-04-01 | 2019-04-03 | 765,992 | — | $0 | 765,992 | SEC↗ |
| Berlin Ronald G. | VP & Chief Operations Office | A Award deriv | 2019-01-15 | 2019-01-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Mainelli Michael | Interim CEO | A Award deriv | 2018-10-15 | 2018-10-15 | 240,000 | — | $0 | 240,000 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | A Award deriv | 2018-09-17 | 2018-09-19 | 765,992 | — | $0 | 765,992 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | A Award deriv | 2018-09-17 | 2018-09-19 | 434,008 | — | $0 | 434,008 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award deriv | 2018-09-17 | 2018-09-19 | 765,992 | — | $0 | 765,992 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award deriv | 2018-09-17 | 2018-09-19 | 434,008 | — | $0 | 434,008 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award deriv | 2018-09-17 | 2018-09-19 | 434,008 | — | $0 | 434,008 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award deriv | 2018-09-17 | 2018-09-19 | 765,992 | — | $0 | 765,992 | SEC↗ |
| Lenzen Kathie J. | Chief Financial Officer | A Award deriv | 2018-09-15 | 2018-09-18 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Brandt Kevin D | VP & Chief Commercial Office | A Award deriv | 2018-08-15 | 2018-08-16 | 30,770 | — | $0 | 30,770 | SEC↗ |
| O'Connell Carl | Chief Executive Officer | A Award deriv | 2018-08-15 | 2018-08-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Brandt Kevin D | VP & Chief Commercial Office | A Award | 2018-08-15 | 2018-08-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Peters Jeffrey J | Director | A Award | 2018-08-15 | 2018-08-16 | 26,042 | — | $0 | 26,042 | SEC↗ |
| McNamara Robert | Director | A Award | 2018-05-02 | 2018-05-04 | 20,833 | — | $0 | 20,833 | SEC↗ |
| BAKEWELL JOHN K | Director | A Award | 2018-04-09 | 2018-04-10 | 26,042 | — | $0 | 26,042 | SEC↗ |
| Mainelli Michael | Director | A Award | 2018-04-08 | 2018-04-10 | 20,833 | — | $0 | 20,833 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-23 | 18,810,000 | $46.56 | $875.79M | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-23 | 1,428,553 | $34.80 | $49.71M | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-23 | 809,614 | $34.80 | $28.17M | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-23 | 33,190,000 | $46.56 | $1.55B | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-26 | 0 | $46.56 | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-26 | 0 | $34.80 | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-26 | 0 | $34.80 | $0 | 0 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-26 | 0 | $46.56 | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-26 | 0 | $46.56 | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-26 | 0 | $46.56 | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-26 | 0 | $34.80 | $0 | 0 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | D To issuer deriv | 2018-02-14 | 2018-02-26 | 0 | $34.80 | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2018-02-14 | 2018-02-23 | 342,132 | $7.20 | $2.46M | 3,316,128 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2018-02-14 | 2018-02-23 | 603,687 | $7.20 | $4.35M | 5,890,884 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | A Award | 2018-02-14 | 2018-02-23 | 2,905,396 | $7.20 | $20.92M | 2,973,996 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | A Award | 2018-02-14 | 2018-02-23 | 5,126,534 | $7.20 | $36.91M | 5,287,197 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award | 2018-02-14 | 2018-02-26 | 2,905,396 | $7.20 | $20.92M | 2,973,996 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | P Buy | 2018-02-14 | 2018-02-26 | 603,687 | $7.20 | $4.35M | 5,890,884 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | P Buy | 2018-02-14 | 2018-02-26 | 342,132 | $7.20 | $2.46M | 3,316,128 | SEC↗ |
| Eggenberg Michael | Director, 10% Owner | A Award | 2018-02-14 | 2018-02-26 | 5,126,534 | $7.20 | $36.91M | 5,287,197 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | P Buy | 2018-02-14 | 2018-02-26 | 342,132 | $7.20 | $2.46M | 3,316,128 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | P Buy | 2018-02-14 | 2018-02-26 | 603,687 | $7.20 | $4.35M | 5,890,884 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award | 2018-02-14 | 2018-02-26 | 2,905,396 | $7.20 | $20.92M | 2,973,996 | SEC↗ |
| Rizzo Matthew | Director, 10% Owner | A Award | 2018-02-14 | 2018-02-26 | 5,126,534 | $7.20 | $36.91M | 5,287,197 | SEC↗ |
| TIMKO ERIC BERNARD | Director | A Award | 2017-07-25 | 2017-07-27 | 51,948 | — | $0 | 51,948 | SEC↗ |
| BUCKMAN PAUL | Director | A Award | 2017-07-25 | 2017-07-27 | 51,948 | — | $0 | 72,049 | SEC↗ |
| LOPACH MICHAEL A | Director | A Award | 2017-07-25 | 2017-07-27 | 51,948 | — | $0 | 95,335 | SEC↗ |
| Swanson Kent L | Director | A Award | 2017-07-25 | 2017-07-27 | 51,948 | — | $0 | 318,641 | SEC↗ |
| Mazzocchi Rudy A | Director | A Award | 2017-07-25 | 2017-07-27 | 51,948 | — | $0 | 51,948 | SEC↗ |
| DEEDRICK JOHN ARTHUR | Director | A Award | 2017-07-25 | 2017-07-27 | 51,948 | — | $0 | 100,434 | SEC↗ |
| Swanson Kent L | Director | X Exercise deriv | 2016-11-17 | 2016-11-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Goldberger Daniel S | Chief Executive Officer | X Exercise deriv | 2016-11-17 | 2016-11-25 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Swanson Kent L | Director | X Exercise | 2016-11-17 | 2016-11-23 | 150,000 | $0.75 | $112.5K | 266,693 | SEC↗ |
| Goldberger Daniel S | Chief Executive Officer | X Exercise | 2016-11-17 | 2016-11-25 | 120,000 | $0.75 | $90.0K | 135,510 | SEC↗ |
| Swanson Kent L | Director | X Exercise deriv | 2016-11-14 | 2016-11-23 | 150,000 | — | $0 | 0 | SEC↗ |
| Goldberger Daniel S | Chief Executive Officer | X Exercise deriv | 2016-11-14 | 2016-11-25 | 120,000 | — | $0 | 0 | SEC↗ |
| O'Connell Carl | President | A Award deriv | 2016-10-06 | 2016-10-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| TIMKO ERIC BERNARD | Director | A Award deriv | 2016-07-05 | 2016-07-06 | 29,700 | — | $0 | 29,700 | SEC↗ |
| Mazzocchi Rudy A | Director | A Award deriv | 2016-07-05 | 2016-07-06 | 29,700 | — | $0 | 29,700 | SEC↗ |
| LOPACH MICHAEL A | Director | A Award | 2016-07-05 | 2016-07-06 | 20,101 | — | $0 | 43,387 | SEC↗ |
| Swanson Kent L | Director | A Award | 2016-07-05 | 2016-07-06 | 20,101 | — | $0 | 116,693 | SEC↗ |
| BUCKMAN PAUL | Director | A Award | 2016-07-05 | 2016-07-06 | 20,101 | — | $0 | 20,101 | SEC↗ |
| DEEDRICK JOHN ARTHUR | Director | A Award | 2016-07-05 | 2016-07-06 | 20,101 | — | $0 | 48,486 | SEC↗ |
| Kirschman David Louis | Director, 10% Owner | D To issuer deriv | 2016-07-02 | 2016-07-06 | 40,000 | — | $0 | 0 | SEC↗ |
| LOPACH MICHAEL A | Director | M Exercise deriv | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 0 | SEC↗ |
| Swanson Kent L | Director | M Exercise deriv | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 0 | SEC↗ |
| WICKWIRE JON M. | Other | M Exercise deriv | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 0 | SEC↗ |
| DEEDRICK JOHN ARTHUR | Director | M Exercise deriv | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 0 | SEC↗ |
| Goodman David | Other | M Exercise deriv | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 0 | SEC↗ |
| LOPACH MICHAEL A | Director | M Exercise | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 23,286 | SEC↗ |
| Swanson Kent L | Director | M Exercise | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 96,592 | SEC↗ |
| WICKWIRE JON M. | Other | M Exercise | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 43,011 | SEC↗ |
| DEEDRICK JOHN ARTHUR | Director | M Exercise | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 28,385 | SEC↗ |
| Goodman David | Other | M Exercise | 2016-07-01 | 2016-07-06 | 11,764 | — | $0 | 11,764 | SEC↗ |
| Goldberger Daniel S | Chief Executive Officer | P Buy | 2016-05-09 | 2016-05-10 | 5,000 | $2.34 | $11.7K | 86,522 | SEC↗ |
| Swanson Kent L | Director | L Small acq | 2015-12-18 | 2015-12-21 | 1,000 | $2.80 | $2.8K | 84,828 | SEC↗ |
| Swanson Kent L | Director | L Small acq | 2015-12-14 | 2015-12-21 | 552 | $3.19 | $1.8K | 83,828 | SEC↗ |
| Swanson Kent L | Director | L Small acq | 2015-12-04 | 2015-12-21 | 148 | $2.81 | $416 | 83,276 | SEC↗ |
| Swanson Kent L | Director | P Buy | 2015-12-03 | 2015-12-03 | 1,000 | $2.83 | $2.8K | 83,128 | SEC↗ |
| Swanson Kent L | Director | P Buy | 2015-12-03 | 2015-12-03 | 300 | $2.81 | $843 | 81,128 | SEC↗ |
| Swanson Kent L | Director | P Buy | 2015-12-03 | 2015-12-03 | 1,000 | $2.82 | $2.8K | 82,128 | SEC↗ |
| Swanson Kent L | Director | P Buy | 2015-12-01 | 2015-12-03 | 1,000 | $2.85 | $2.9K | 80,828 | SEC↗ |
| Swanson Kent L | Director | P Buy | 2015-11-20 | 2015-11-20 | 4,976 | $3.00 | $14.9K | 79,828 | SEC↗ |
| Kirschman David Louis | EVP & Chief Scientific Offic | P Buy | 2015-11-20 | 2015-11-23 | 1,000 | $2.94 | $2.9K | 1,700,063 | SEC↗ |
| Kirschman David Louis | EVP & Chief Scientific Offic | P Buy | 2015-11-20 | 2015-11-23 | 1,000 | $3.04 | $3.0K | 1,701,063 | SEC↗ |
| Kirschman David Louis | EVP & Chief Scientific Offic | P Buy | 2015-11-19 | 2015-11-19 | 1,000 | $2.94 | $2.9K | 1,699,063 | SEC↗ |
| Swanson Kent L | Director | P Buy | 2015-11-19 | 2015-11-20 | 24 | $2.90 | $70 | 74,852 | SEC↗ |
| Kirschman David Louis | EVP & Chief Scientific Offic | P Buy | 2015-11-18 | 2015-11-19 | 1,000 | $2.86 | $2.9K | 1,698,063 | SEC↗ |
| Goldberger Daniel S | Chief Executive Officer | P Buy | 2015-11-16 | 2015-11-16 | 3,000 | $2.80 | $8.4K | 15,510 | SEC↗ |